市場調查報告書
商品編碼
1468151
2024-2032 年眼科黏彈性器材市場(按產品、應用、最終用戶和地區分類)Ophthalmic Viscoelastic Devices Market by Product, Application, End User, and Region 2024-2032 |
IMARC Group年,全球眼科黏彈性器械(OVD)市場規模達27億美元。眼科手術數量的增加、廣泛的研發 (R&D) 活動以及醫療保健行業的不斷成長是推動市場發展的一些關鍵因素。
眼科黏彈性裝置(OVD)是眼科手術期間使用的醫療設備。它們用於眼科和許多眼科手術,例如青光眼、角膜移植、玻璃體視網膜和白內障手術。這些裝置可保護眼部結構免受機械創傷、分割組織、創造空間、解決沾黏、作為潤濕劑或作為促進外科手術的器械。 OVD 廣泛用於在人工水晶體 (IOL) 植入過程中維持眼內空間、穩定和加深前房以及在眼前節手術過程中保護眼部結構。這些設備有助於在前房內產生壓力,分類注意力,並提供更快、更安全的手術,讓患者更好地康復。
全球眼科手術數量的增加是推動市場成長的關鍵因素之一。 OVD 廣泛用於維持、保留空間、置換、穩定和保護組織。與此一致,改善眼科護理設施的可近性和提高對眼部疾病的認知是另一個促進成長的因素。此外,由於複雜眼科手術病例數量的增加,黏性適應性眼科黏性手術設備的廣泛使用及其消除對兩個注射器的需求的雙相優勢正在推動市場成長。除此之外,黏性適應性OVD在複雜的眼科手術中也是首選,例如小兒白內障手術、虹膜鬆弛綜合症患者、外傷、Fuchs營養不良等,以避免術後併發症,這反過來又有利於市場成長。除此之外,引入包含在單一單位中的黏性和分散OVD 組合包,該組合包在手術過程中同時使用,具有成本效益,可確保品質標準並簡化眼外科醫生的活動,這為市場提供了動力生長。此外,老年人口的增加以及糖尿病和與年齡相關的眼部疾病盛行率的增加正在對市場成長產生積極影響。其他因素包括消費者支出能力的提高、廣泛的研發(R&D)活動、醫療保健行業的顯著擴張,以及政府實施各種舉措,透過迫使生產商引進新的眼科設備來控制日益嚴重的視力損害。為市場創造積極的前景。
The global ophthalmic viscoelastic devices (OVD) market size reached US$ 2.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.7 Billion by 2032, exhibiting a growth rate (CAGR) of 3.52% during 2024-2032. The increasing number of ophthalmic surgeries, extensive research and development (R&D) activities, and escalating growth in the healthcare industry represent some of the key factors driving the market.
Ophthalmic viscoelastic devices (OVD) are medical equipment used during eye surgeries. They are employed in ophthalmic and numerous eye surgeries, such as glaucoma, corneal transplant, and vitreoretinal and cataract surgery. These devices protect ocular structures from mechanical trauma, divide tissue, create space, resolve adhesions, act as a wetting agent, or as an instrument to facilitate the surgical procedure. OVDs are widely used to maintain space in the eye during intraocular lens (IOL) implantation, stabilize and deepen the anterior chamber, and protect ocular structures during anterior segment surgery. These devices assist in creating pressure within the anterior chamber, compartmentalizing inside the attention, and providing a faster and safer surgery with better recovery for the patients.
The increasing number of ophthalmic surgeries across the globe is one of the key factors driving the market growth. OVDs are widely used to maintain, preserve space, displace, stabilize, and protect tissues. In line with this, improving access to ophthalmic care facilities and rising awareness about ocular disorders are acting as another growth-inducing factor. Moreover, the widespread utilization of viscoadaptive ophthalmic viscosurgical devices due to the increasing number of complex ocular surgical cases and its biphasic benefit of eliminating the need for two syringes is propelling the market growth. In addition to this, viscoadaptive OVD is also preferred in complex ocular surgeries, such as pediatric cataract surgery, patient with floppy iris syndrome, trauma, Fuchs dystrophy, and other cases to avoid post-surgical complications, which, in turn, is favoring the market growth. Apart from this, the introduction of a combination package of cohesive and dispersive OVD contained in a single unit, that is used simultaneously during procedures and is cost-effective, ensures quality standards and eases out ophthalmic surgeons' activities is providing an impetus to the market growth. Additionally, the rising geriatric population and the increasing prevalence of diabetes and age-related ocular disorders are positively influencing the market growth. Other factors, including the rising expenditure capacities of consumers, extensive research and development (R&D) activities, significant expansion in the healthcare industry, and the implementation of various government initiatives to control the rising vision impairment by compelling producers to introduce new ophthalmic equipment, are creating a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each segment of the global ophthalmic viscoelastic devices (OVD) market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on product, application, and end user.
Cohesive Ophthalmic Viscoelastic
Dispersive Ophthalmic Viscoelastic
A detailed breakup and analysis of the ophthalmic viscoelastic devices (OVD) market based on the product has also been provided in the report. This includes cohesive and dispersive ophthalmic viscoelastic. According to the report, cohesive ophthalmic viscoelastic accounted for the largest market share.
Cataract Surgery
Glaucoma Surgery
Corneal Transplant
Vitreoretinal Surgery
The report has provided a detailed breakup and analysis of the ophthalmic viscoelastic devices (OVD) market based on the application. This includes cataract surgery, glaucoma surgery, corneal transplant, and vitreoretinal surgery. According to the report, cataract surgery represented the largest segment.
Hospitals
Ophthalmic Clinics
Others
A detailed breakup and analysis of the ophthalmic viscoelastic devices (OVD) market based on the end user has also been provided in the report. This includes hospitals, ophthalmic clinics, and others. According to the report, hospitals accounted for the largest market share.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for ophthalmic viscoelastic devices (OVD). Some of the factors driving the North America ophthalmic viscoelastic devices (OVD) market included extensive research and development (R&D) activities, the rising geriatric population, and the increasing prevalence of diabetes and age-related ocular disorders.
The report has also provided a comprehensive analysis of the competitive landscape in the global ophthalmic viscoelastic devices (OVD) market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Alcon Inc., Altacor Limited, Bausch Health Companies Inc., Bohus Biotech Ab, Carl Zeiss Meditec Ag, Cima Technology Inc, Eyekon Medical Inc., Johnson & Johnson, RUMEX International Co., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.